Selective Estrogen Receptor Modulators (SERMs) undoubtedly are a cornerstone of pharmaceutical PCT interventions. They operate as aggressive inhibitors at estrogen receptors during the hypothalamus when exhibiting tissue-selective agonist or antagonist Houses all over the entire body. SERMs are vital in regulating post cycle estrogen production and